Jazz Pharmaceuticals, Inc (Nasdaq: JAZZ) has filed an amended S-1 statement with the SEC. The Company now expects the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE